Discovery, identification and mitigation of isobaric sulfate metabolite interference to a phosphate prodrug in LC–MS/MS bioanalysis: Critical role of method development in ensuring assay quality-Reference-Cited by-同舟云学术

Discovery, identification and mitigation of isobaric sulfate metabolite interference to a phosphate prodrug in LC–MS/MS bioanalysis: Critical role of method development in ensuring assay quality

Published:2018-06 Issue: Volume:155 Page:141-147
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Yuan Long^ORCID,Ji Qin C.

Funder

Mohammed Jemal

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference32 articles.

1. Prodrug strategies to overcome poor water solubility;Stella;Adv. Drug Deliv. Rev.,2007

2. Prodrugs: design and clinical applications;Rautio;Nat. Rev. Drug Discov.,2008

3. Prodrugs—from serendipity to rational design;Huttunen;Pharmacol. Rev.,2011

4. Prodrugs A challenge for the drug development;Zawilska;Pharmacol. Rep.,2013

5. Prodrug strategy for cancer cell-specific targeting: a recent overview;Zhang;Eur. J. Med. Chem.,2017

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reliable quantification of citrate isomers and isobars with direct-infusion tandem mass spectrometry;Talanta;2023-07

2. 2020 White Paper on Recent Issues in Bioanalysis: BAV Guidance, CLSI H62, Biotherapeutics Stability, Parallelism Testing, CyTOF and Regulatory Feedback (Part 2A – Recommendations on Biotherapeutics Stability, PK LBA Regulated Bioanalysis, Biomarkers Assays, Cytometry Validation & Innovation Part 2B – Regulatory Agencies’ Inputs on Bioanalysis, Biomarkers, Immunogenicity, Gene & Cell Therapy and Vaccine);Bioanalysis;2021-03

3. Challenges and recommendations in developing LC–MS/MS bioanalytical assays of labile glucuronides and parent compounds in the presence of glucuronide metabolites;Bioanalysis;2020-05

4. Bioanalysis of biological matrix samples using liquid chromatography–tandem mass spectrometry detection;Specification of Drug Substances and Products;2020

5. Bioanalysis of small and large molecule drugs, metabolites, and biomarkers by LC-MS;Identification and Quantification of Drugs, Metabolites, Drug Metabolizing Enzymes, and Transporters;2020